Follow
Kevin Maynard
Kevin Maynard
Verified email at brookes.ac.uk
Title
Cited by
Cited by
Year
Cross-Sensitivity of Methylating Agents, Hydroxyurea, and Methotrexate in Human Tumor Cells of the Mer- Phenotype
K Maynard, PG Parsons
Cancer research 46 (10), 5009-5013, 1986
401986
Relationships among Cell Survival, O6-Alkylguanine-DNA Alkyltransferase Activity, and Reactivation of Methylated Adenovirus 5 and Herpes Simplex Virus Type 1 …
K Maynard, PG Parsons, T Cerny, GP Margison
Cancer research 49 (17), 4813-4817, 1989
251989
Single sensor gait analysis to detect diabetic peripheral neuropathy: a proof of principle study
P Esser, J Collett, K Maynard, D Steins, A Hillier, J Buckingham, GD Tan, ...
Diabetes & Metabolism Journal 42 (1), 82, 2018
232018
Use of host cell reactivation of cisplatin-treated adenovirus 5 in human cell lines to detect repair of drug-treated DNA.
KR Maynard, LK Hosking, BT Hill
Chemico-biological interactions 71 (4), 353-365, 1989
131989
Adenovirus replication as an in vitro probe for drug sensitivity in human tumors
PG Parsons, KR Maynard, JH Little, GR McLeod
European Journal of Cancer and Clinical Oncology 22 (4), 401-409, 1986
131986
Pain free blunt needle injection technology
P Crocker, K Maynard, M Little
Innov Pharm Technol 9, 111-115, 2001
52001
Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell lines
PG Parsons, DJ Moss, C Morris, P Musk, K Maynard, R Partridge
International journal of cancer 35 (6), 743-747, 1985
41985
MELPHALAN‐RESISTANT LYMPHOBLASTOID CELL LINES ESTABLISHED FROM PATIENTS WITH OVARIAN CANCER TREATED WITH CROSS‐LINKING AGENTS
K Maynard, P Musk, B Daunter, SK Khoo, PG Parsons
Australian journal of experimental biology and medical science 63 (3), 333-341, 1985
41985
DepotOne: a technology to make large needle injections more acceptable
K Maynard, P Croker, M Little
DRUG DELIVERY SYSTEMS AND SCIENCES 3, 71-74, 2003
12003
Improving the Delivery of Complex Formulations Using the DepotOne Needle
K Maynard, P Crocker
Modified-Release Drug Delivery Technology, 187-198, 2008
2008
From pain to gain
K Maynard
DRUG DELIVERY SYSTEMS AND SCIENCES 5 (2), 49, 2005
2005
NOVEL METHODS FOR INCREASING THE NUMBER OF CLONES EXPRESSING SENSITIVITY TO A CYTO-TOXIC AGENT IN A TUMOR-CELL POPULATION
K MAYNARD, BT HILL
BRITISH JOURNAL OF CANCER 60 (3), 495-495, 1989
1989
Resistance to alkylating agents in human melanoma and lymphoblastoid cells
KR Maynard
University of Queensland, 1986
1986
THE MER-PHENOTYPE IN HUMAN-MELANOMA CELL-LINES
K MAYNARD, PG PARSONS
PROCEEDINGS OF THE AUSTRALIAN BIOCHEMICAL SOCIETY 16, 99-99, 1984
1984
The system can't perform the operation now. Try again later.
Articles 1–14